SEATTLE, WA and LUND, SWEDEN / ACCESSWIRE / November 11, 2024 / Aptevo Therapeutics ("Aptevo") (Nasdaq:APVO) and Alligator Bioscience AB ("Alligator") (ATORX) today announced preliminary data from the ...
DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (LTRN), a leading artificial intelligence (AI)-driven oncology company leveraging its proprietary RADR ® platform to accelerate targeted cancer therapies, ...
Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback